IntrinsicIntrinsic
← Scroll for more →

Financial Statements — BLRX

Balance Sheet

(in millions USD)
MetricQ4 2025Q2 2025Q4 2024Q2 2024Q4 2023Q2 2023Q4 2022Q2 2022Q4 2021Q2 2021
Cash & Equivalents3.257.1910.449.624.2610.1010.5914.0012.9917.48
Inventory2.152.853.153.631.95----------
Total Current Assets23.6831.8627.1049.1147.1834.6952.0044.1057.4067.07
Total Non-current Assets17.2211.4111.8015.4916.7424.2424.3823.7423.9924.26
Total Assets40.9143.2738.9164.6063.9358.9476.3867.8481.3991.33
Total Current Liabilities12.1215.4815.4130.5230.8512.4510.689.639.729.92
Total Non-current Liabilities5.447.7210.0420.1019.8525.4414.861.643.597.52
Total Liabilities17.5623.2025.4550.6250.7037.8825.5411.2713.3017.44
Retained Earnings(401.00)(398.64)(399.83)(390.82)(390.61)(360.70)(329.99)(317.41)(305.04)(295.02)
Total Stockholder Equity23.3520.0713.4613.9813.2221.0550.8456.5768.0973.89
← Scroll for more columns →

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q2 2021
Total Revenue0.305.39------
Cost of Revenue*0.070.90------
Gross Profit0.234.50------
Research & Development2.332.233.015.405.14
Selling, General & Admin0.211.631.311.051.04
Total Operating Expenses*2.5410.27------
Operating Income(2.30)(5.77)(9.91)(7.60)(6.51)
Net Income(3.94)0.48(18.55)(7.44)(6.84)
Basic EPS0.000.00(0.02)(0.01)--
Diluted EPS0.000.00(0.02)(0.01)--
← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in millions USD)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q2 2021
Operating Cash Flow(2.77)(25.44)(17.70)(11.87)(13.06)
Investing Cash Flow(11.88)8.0417.7415.08(42.26)
Financing Cash Flow11.0522.99(0.18)(1.63)56.00
← Scroll for more columns →